🚀 Economists Question White House's Tariff Income Claims

In partnership with

Own shares in a revolutionary sleep technology startup.

Smart Nora’s patented solution has already brought better sleep to more than 100,000 customers. The company is now bringing this technology to millions of people who can not tolerate CPAPs and other invasive snoring and sleep apnea solutions. Sleep apnea awareness and detection are at all times high. This is the perfect opportunity to join them.

Invest Now

Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.smartnora.com. This is a paid advertisement for Smart Nora, LLC's Reg CF campaign.

Market Overview
Read time 1.4 minutes

Year To Date Performances:

1. White House trade adviser Peter Navarro claims tariffs could generate $600–700 billion annually, but economists say the real figure is likely less than half that. A proposed 20% tariff on imports could theoretically yield $660 billion based on 2024 trade figures, but analysts argue that economic slowdowns, reduced consumer demand, and foreign retaliation will cut revenue significantly. Yale Budget Lab estimates a more realistic $250 billion per year. The White House also claims that tariffs can replace income tax; however, since tariffs are being issued via executive order, experts doubt they’ll last a decade, weakening their role in funding Trump’s proposed tax cuts.

2. Hims & Hers shares rose 5% after announcing it will offer Eli Lilly’s weight-loss drug Zepbound, diabetes drug Mounjaro, and generic liraglutide on its platform. The company has navigated supply and regulatory challenges in the booming GLP-1 market, previously benefiting from compounded semaglutide sales before FDA restrictions limited its availability. While expanding its weight-loss portfolio, Hims & Hers expects $725 million in revenue from the segment, excluding compounded drugs, and is lobbying to maintain access to compounded treatments. The stock is up 27% this year after a 172% surge in 2024.

3. Mortgage rates remain nearly unchanged, with the average 30-year fixed rate dipping slightly to 6.70% from 6.71%, while mortgage demand shows mixed signals. Purchase applications rose 2% for the week and are up 9% year-over-year, reflecting growing homebuyer interest amid increased inventory. However, refinance applications fell 6% but remain 57% higher than a year ago due to a low base effect. Markets remain cautious as uncertainty over potential tariffs keeps mortgage rates in a tight range.

4. Headlines

   1. Israel plans to seize parts of Gaza in the latest military operation announced yesterday.

   2. Republicans won both special congressional elections in Florida.

   _{* This is sponsored content.}

Are you looking to grow your business? Here is how I can help: 

📱Book a Strategy Call to get 1:1 feedback on your pitch, pitch deck and/or fundraising strategy. (If you need general startup advice, then reply to this email, and I’ll let you know if/how I can help.)

This Smart Home Company Grew 200% Year-Over-Year…

Ring and Nest transformed security and climate control—now RYSE is doing the same for window shades.

With $10M+ in revenue, 127 Best Buy locations, and expansion into Home Depot in 2025, RYSE is positioned to dominate the smart shade market. Their patented retrofit technology makes automation easy—no costly replacements needed.

The smart home market is booming, and RYSE’s public offering is live at $1.90/share. Invest now before their next phase of growth.

Invest Today and Receive Up To 25% in Bonus Shares

_{Past performance is not indicative of future results. Email may contain forward-looking statements. See US Offering for details. Informational purposes only.}

Onwards and Upwards,

Liam Gill